JVASX
Price
$39.66
Change
+$0.18 (+0.46%)
Updated
Jul 3 closing price
Net Assets
9.13B
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

JVASX vs VVIAX

Header iconJVASX vs VVIAX Comparison
Open Charts JVASX vs VVIAXBanner chart's image
JPMorgan Value Advantage I
Price$39.66
Change+$0.18 (+0.46%)
VolumeN/A
Net Assets9.13B
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
JVASX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JVASX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVASX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. JVASX (9.13B). VVIAX pays higher dividends than JVASX: VVIAX (2.18) vs JVASX (1.41). JVASX was incepted earlier than VVIAX: JVASX (20 years) vs VVIAX (25 years). JVASX (0.84) is less costly to investors than VVIAX (0.05). JVASX is a more actively managed with annual turnover of: 17.00 vs. VVIAX (9.00). VVIAX has a lower initial minimum investment than JVASX: VVIAX (3000) vs JVASX (1000000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. JVASX (7.13). VVIAX return over 5 years is better than : 80.13 vs. JVASX (41.66).
JVASXVVIAXJVASX / VVIAX
Total Expense Ratio0.740.051,480%
Annual Report Gross Expense Ratio0.840.051,680%
Fund Existence20 years25 years-
Gain YTD5.5916.19890%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets9.13B189B5%
Annual Yield % from dividends1.412.1865%
Returns for 1 year7.1312.0359%
Returns for 3 years11.4535.1733%
Returns for 5 years41.6680.1352%
Returns for 10 years46.04115.6740%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.